Holen Sie sich die Stockscreener-App
30.71
1.54%
-0.48
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
Loomis Sayles & Co. L P Has $737,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Penserra Capital Management LLC Invests $757,000 in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Rubric Capital Management LP Lowers Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Brokerages Set Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Target Price at $42.60 - Defense World
Collegium Pharmaceutical: Strong Growth With Pain Management And ADHD Expansion - Seeking Alpha
Massachusetts Financial Services Co. MA Increases Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Pacer Advisors Inc. Sells 818,721 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Is the Options Market Predicting a Spike in Collegium Pharmaceutical (COLL) Stock? - MSN
Amalgamated Bank Has $372,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
121,446 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Acquired by Empowered Funds LLC - MarketBeat
Victory Capital Management Inc. Purchases 215,874 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Shareholders Can Be Confident That Collegium Pharmaceutical's (NASDAQ:COLL) Earnings Are High Quality - Simply Wall St
Collegium Pharmaceutical's (NASDAQ:COLL) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Rubric Capital Management LP Adjusts Stake in Collegium Pharmace - GuruFocus.com
Is Collegium Pharmaceutical (COLL) a Great Value Stock Right Now? - MSN
Collegium Pharmaceutical Inc (COLL) Stock Price Down 3.67% on No - GuruFocus.com
Collegium to Participate in Upcoming Investor Conferences - GlobeNewswire
Collegium Pharmaceutical to Present at Major Healthcare Investor Conferences | COLL Stock News - StockTitan
Meritage Portfolio Management Purchases New Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
New York State Teachers Retirement System Lowers Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Principal Financial Group Inc. Has $67.46 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2024 Earnings Call Transcript - Insider Monkey
Collegium Pharmaceutical Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Bought by Robeco Institutional Asset Management B.V. - MarketBeat
Collegium appoints new CEO Vikram Karnani By Investing.com - Investing.com Australia
Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag Estimates - MSN
Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings - MSN
Collegium Pharmaceutical: Q3 Earnings Snapshot - The Washington Post
Collegium Pharmaceutical Reports Strong Q3 2024 Results - TipRanks
Collegium Pharmaceutical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Collegium Pharmaceutical Taps Vikram Karnani as CEO - MarketWatch
Collegium Pharmaceutical earnings beat by $0.04, revenue topped estimates - Investing.com UK
Collegium appoints new CEO Vikram Karnani - Investing.com
Collegium Reports Record Third Quarter 2024 Financial Results - GlobeNewswire
Collegium Appoints Vikram Karnani as Chief Executive Officer - GlobeNewswire
Collegium Pharma Names Growth Expert Karnani as CEO Amid Record Revenue Success | COLL Stock News - StockTitan
A Preview Of Collegium Pharmaceutical's Earnings - Benzinga
What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings - Yahoo Finance
Collegium Pharmaceutical is Now Oversold (COLL) - Nasdaq
Emerald Advisers LLC Acquires 177,129 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $42.60 Average Target Price from Analysts - Defense World
(COLL) Trading Report - Stock Traders Daily
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Collegium Pharmaceutical (COLL) Set to Announce Quarterly Earnings on Thursday - MarketBeat
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Allspring Global Investments Holdings LLC Has $3.08 Million Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Assenagon Asset Management S.A. Sells 188,423 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - MarketBeat
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? - MSN
0.83%
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):